Thymoquinone, as an anticancer molecule: from basic research to clinical investigation
- PMID: 28881699
- PMCID: PMC5584300
- DOI: 10.18632/oncotarget.17206
Thymoquinone, as an anticancer molecule: from basic research to clinical investigation
Abstract
Thymoquinone is an anticancer phytochemical commonly found in black cumin. In this review, we discuss the potential of thymoquinone as anticancer molecule, its mechanism of action and future usage in clinical applications. Thymoquinone exhibits anticancer activity via numerous mechanisms of action, specifically by showing selective antioxidant and oxidant activity, interfering with DNA structure, affecting carcinogenic signaling molecules/pathways and immunomodulation. In vitro activity of thymoquinone has been further implicated in animal models of cancer; however, no clinical application has been proven yet. This is the optimum time to focus on clinical trials for developing thymoquinone as a future drug in cancer therapeutics.
Keywords: Nigella sativa; anticancer; clinical studies; mouse model; thymoquinone.
Conflict of interest statement
CONFLICTS OF INTEREST The authors declare that there is no conflicts of interest regarding this paper.
Figures
References
-
- Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–289. - PubMed
-
- Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
